ES2022771A6 - Procedimiento para preparar derivados de adenosina. - Google Patents

Procedimiento para preparar derivados de adenosina.

Info

Publication number
ES2022771A6
ES2022771A6 ES8904209A ES8904209A ES2022771A6 ES 2022771 A6 ES2022771 A6 ES 2022771A6 ES 8904209 A ES8904209 A ES 8904209A ES 8904209 A ES8904209 A ES 8904209A ES 2022771 A6 ES2022771 A6 ES 2022771A6
Authority
ES
Spain
Prior art keywords
alkyl
adenosines
trisubstituted
disubstituted
methallyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES8904209A
Other languages
English (en)
Inventor
Fulvio Gadient
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES2022771A6 publication Critical patent/ES2022771A6/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/167—Purine radicals with ribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR DERIVADOS DE ADENOSINA, DE FORMULA (I) EN DONDE RSI1 ES ALILO, METALILO, ALQUINILO, CICLOALQUILO O FENILO, RSI2 ES HIDROGENO, ALQUILO, CICLOALQUILO O HALOGENO Y RSI3 ES ALQUILO. COMPRENDE REACCIONAR UN COMPUESTO (II) CON UN COMPUESTO RSI1-NHS
ES8904209A 1988-12-13 1989-12-13 Procedimiento para preparar derivados de adenosina. Expired - Lifetime ES2022771A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3841881 1988-12-13

Publications (1)

Publication Number Publication Date
ES2022771A6 true ES2022771A6 (es) 1991-12-01

Family

ID=6369027

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8904209A Expired - Lifetime ES2022771A6 (es) 1988-12-13 1989-12-13 Procedimiento para preparar derivados de adenosina.

Country Status (29)

Country Link
US (1) US5534503A (es)
JP (2) JPH0725786B2 (es)
KR (1) KR900009647A (es)
AT (1) AT397964B (es)
AU (1) AU618865B2 (es)
BE (1) BE1003632A3 (es)
CA (1) CA2005110A1 (es)
CH (1) CH678327A5 (es)
CS (1) CS411191A3 (es)
CY (1) CY1829A (es)
DE (1) DE3940021C2 (es)
DK (1) DK626989A (es)
ES (1) ES2022771A6 (es)
FR (1) FR2640271B1 (es)
GB (1) GB2226027B (es)
HK (1) HK70895A (es)
HU (1) HU211248A9 (es)
IE (1) IE65506B1 (es)
IL (1) IL92634A (es)
IT (1) IT1237431B (es)
LU (1) LU87639A1 (es)
MX (1) MX9203613A (es)
MY (1) MY106333A (es)
NL (1) NL8903054A (es)
NZ (1) NZ231701A (es)
PH (1) PH27533A (es)
SE (1) SE8904186L (es)
SG (1) SG8695G (es)
ZA (1) ZA899528B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0725785B2 (ja) * 1989-01-11 1995-03-22 日本臓器製薬株式会社 アデノシン誘導体及び該化合物を有効成分として含有する医薬組成物
DE4037363A1 (de) * 1990-04-09 1991-10-10 Europ Lab Molekularbiolog 2-0-alkylnukleotide sowie polymere, die solche nukleotide enthalten
DK0550631T3 (da) * 1990-09-25 1997-01-20 Rhone Poulenc Rorer Int Forbindelser med blodtrykssænkende virkning og virkning mod iskæmi
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
HUT61567A (en) * 1990-12-07 1993-01-28 Sandoz Ag Process for producing new pharmaceutical compositions comprising 2'-o-alkyladenosine derivatives and for producing 6-cyclohexyl-2'-o-methyladenosinehydrate
GB9111580D0 (en) * 1991-05-30 1991-07-24 Wellcome Found Nucleoside derivative
EP0601322A3 (en) * 1992-10-27 1994-10-12 Nippon Zoki Pharmaceutical Co Adenosine deaminase inhibitor.
WO1995030683A1 (en) * 1994-05-10 1995-11-16 Sandoz Ltd. Adenosine derivatives
US6107300A (en) * 1996-03-27 2000-08-22 Dupont Pharmaceuticals Arylamino fused pyrimidines
JP3619017B2 (ja) 1998-06-24 2005-02-09 日本臓器製薬株式会社 新規アラビノシルアデニン誘導体

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130136C (es) * 1966-10-20
DE2628202A1 (de) * 1976-06-23 1977-12-29 Max Planck Gesellschaft Verfahren zur herstellung von 2'-substituierten-d-ribofuranosylpurinderivaten
CA1239397A (en) * 1983-08-01 1988-07-19 James A. Bristol N.sup.6-substituted adenosines
DE3406533A1 (de) * 1984-02-23 1985-08-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten
AU575438B2 (en) * 1984-10-26 1988-07-28 Warner-Lambert Company N6 - substituted deoxyribose analogues of adenosines
US4755594A (en) * 1986-01-31 1988-07-05 Warner-Lambert Company N6 -substituted adenosines
US4780452A (en) * 1986-09-08 1988-10-25 Burroughs Wellcome Co. F-substituted-3-β-D-ribofuranosyl-3H-imidazo[4,5-b]pyridines and pharmaceutical compositions thereof
AU8274187A (en) * 1986-10-31 1988-05-25 Warner-Lambert Company Heteroaromatic derivatives of adenosine
JPH0723394B2 (ja) * 1986-11-27 1995-03-15 日本臓器製薬株式会社 新規アデノシン誘導体及び該化合物を有効成分として含有する医薬組成物
US4962194A (en) * 1987-04-02 1990-10-09 Warner-Lambert Company Method of preparing 51,N6-disubstituted adenosines from inosines
GB8729994D0 (en) * 1987-12-23 1988-02-03 Glaxo Group Ltd Chemical compounds
JPH0725785B2 (ja) * 1989-01-11 1995-03-22 日本臓器製薬株式会社 アデノシン誘導体及び該化合物を有効成分として含有する医薬組成物

Also Published As

Publication number Publication date
FR2640271B1 (fr) 1995-02-03
HK70895A (en) 1995-05-19
PH27533A (en) 1993-08-18
IE65506B1 (en) 1995-11-01
JPH02218689A (ja) 1990-08-31
CS411191A3 (en) 1992-06-17
CH678327A5 (es) 1991-08-30
JPH07223961A (ja) 1995-08-22
BE1003632A3 (fr) 1992-05-12
LU87639A1 (fr) 1991-09-18
ATA280489A (de) 1993-12-15
DK626989D0 (da) 1989-12-12
HU211248A9 (en) 1995-11-28
SG8695G (en) 1995-06-16
AU618865B2 (en) 1992-01-09
JPH0725786B2 (ja) 1995-03-22
GB2226027B (en) 1992-05-20
NL8903054A (nl) 1990-07-02
MY106333A (en) 1995-05-30
FR2640271A1 (fr) 1990-06-15
MX9203613A (es) 1992-07-01
DE3940021C2 (de) 1994-08-25
IE893965L (en) 1990-06-13
SE8904186L (sv) 1991-06-13
KR900009647A (ko) 1990-07-05
NZ231701A (en) 1992-09-25
GB2226027A (en) 1990-06-20
AU4617289A (en) 1990-06-21
IL92634A0 (en) 1990-08-31
IT1237431B (it) 1993-06-04
SE8904186D0 (sv) 1989-12-12
AT397964B (de) 1994-08-25
DE3940021A1 (de) 1990-06-21
DK626989A (da) 1990-06-14
ZA899528B (en) 1991-08-28
IL92634A (en) 1994-01-25
CA2005110A1 (en) 1990-06-13
IT8948640A0 (it) 1989-12-12
US5534503A (en) 1996-07-09
CY1829A (en) 1995-12-01
GB8925439D0 (en) 1989-12-28

Similar Documents

Publication Publication Date Title
NO171684C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktiv polyetylenglykolkarbaminater
AU6782090A (en) 2-substituted phenyl-2-oxazoline or thiazoline derivatives, process for producing the same and insectides and acaricides containing the same
DE69025336T2 (de) Antihypertensive Zubereitungen und deren Verwendung
EP0380048A3 (en) Use of benzoyl urea derivatives as antiviral agents
ES2022771A6 (es) Procedimiento para preparar derivados de adenosina.
HUP0402385A2 (hu) 5-Fenil-pirimidinek, ezeket tartalmazó fungicid készítmények, eljárás előállításukra és alkalmazásuk
ES2004141A6 (es) Un procedimiento de preparacion de nuevas 1,4-dihidropiridinas
ZA902649B (en) Heteroaryl-3-oxo-propanenitrile derivatives useful in the treatment of rheumatoid arthritis and other autoimmune diseases
AU625886B2 (en) New oxazolopyridine derivatives, process for preparing them and pharmaceutical compositions containing them
ES2010145A6 (es) Procedimiento para la obtencion de derivados de la 2-picolilamina.
HU913502D0 (en) Process for the production of medical prepartions for fighting human retrovirus, containing xantine derivatives as active agents
HUT49283A (en) Process for production of medical compositions applicable for treatment of peptical ulcer
MY103293A (en) N-imidazolyl derivatives of bicyclic compounds useful in medicine
GR3001611T3 (en) Substituted aminomethane-diphosphonic acids
KR910002456A (ko) 당뇨병 치료용 제약 조성물
FI932188A (fi) Oktahydronaftalenoximderivat foer inhibering av kolesterolbiosyntesen, deras framstaellning och anvaendning
ES466168A1 (es) Procedimiento para la preparacion de nuevos derivados de cromonas dotados de actividad medicamentosa
FR2698789B1 (fr) Utilisation de l'idazoxan et ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson et de son évolution.
AU3376193A (en) The use of xanthine derivatives for the treatment of muscle damage after interruption of the blood circulation
DE69029069D1 (de) Verwendung von Xanthinderivaten gegen Magengeschwüre
DK653687A (da) Middel til behandling af nyresygdomme
TH13401EX (th) อนุพันธ์ของออคทะไฮโดรแนฟธาลีน ออกซีมสำหรับการยับยั้งชีวสังเคราะห์ของคอเลสเตอรอลการเตรียมและการใช้ประโยชน์ของอนุพันธ์เหล่านี้
ES2078139B1 (es) Composiciones antirretrovirales que contienen compuestos iodados.

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2009-12-13

PC1A Transfer granted
FD1A Patent lapsed

Effective date: 20010402